Vaccine for whooping cough, diphtheria, and tetanus in teens and adults
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new combined vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and how well it works to boost immunity in teens and adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 10 years of age or older.
- You have not recently received a diphtheria, tetanus, or whooping cough vaccine (within 3 years for ages 10-11; within 5 years for ages 12+).
- You are not pregnant, breastfeeding, or planning to conceive within 6 months, and you will use effective contraception if needed.
- You do not have serious chronic health conditions like severe heart disease or uncontrolled high blood pressure.
- You have no history of severe allergic reactions to vaccines or their components.
- You do not have a weakened immune system (from disease or immune-suppressing medications).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.
This study tests a lower-dose vaccine that protects against diphtheria, tetanus, and whooping cough. It aims to see if the vaccine is safe and how well it works for people aged 6 and older, possibly offering a booster with fewer side effects.
This study checks if the protection from an earlier vaccine (against whooping cough, diphtheria, and tetanus) lasts over time. Participants from a previous study will give blood samples to measure their immune response.
This study tests a new type of whooping cough vaccine given to pregnant women to see if it helps protect their babies from whooping cough in the first months of life. The vaccine is given during pregnancy, and then the baby's immune response is checked up to 15–18 months old.
This study tests what happens when healthy adults are exposed to a special type of whooping cough bacteria. Results may help develop better vaccines to protect people from this infection.
This trial tests a new medicine made from antibodies that target tetanus toxin. It may help protect people from tetanus without needing a vaccine.
Hear when a new Pertussis (Whooping Cough) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.